FORT LAUDERDALE, Fla. – A once high-flying, multi-state autism therapy firm, ABA Centers of America, headquartered in Fort Lauderdale, has acknowledged it is the subject of an intense federal investigation into its billing practices. The revelation casts a dark shadow over a company that soared to national prominence in just six years, now facing allegations ranging from healthcare fraud to conspiracy to commit money laundering. The probe, led by the U.S. Department of Health and Human Services, coupled with concurrent multi-million dollar civil lawsuits, suggests a systemic pattern of alleged misconduct that could have far-reaching implications for the burgeoning autism therapy sector.
n
The company, and its parent entity ICBD Holdings, confirmed it is "working" with federal investigators, while staunchly denying any wrongdoing. However, an 81-page federal affidavit unsealed in New Hampshire details a wide array of alleged offenses, painting a picture of a business model driven by profit maximization at the expense of legitimate medical necessity and ethical billing. The scandal has already led to Temple University retracting a historic $55 million philanthropic pledge from the company’s founder, Christopher M. Barnett, and rescinding the renaming of its College of Public Health in his honor.
n
Allegations of a Profit-Driven Scheme Unveiled
n
At the heart of the federal investigation are grave allegations concerning ABA Centers of America’s billing practices. According to the federal affidavit submitted to a New Hampshire magistrate, investigators are scrutinizing possible offenses including false statements relating to health matters, wire fraud, healthcare fraud, conspiracy to commit money laundering, and transacting in criminal proceeds. Prosecutors from the fraud section of the U.S. Justice Department’s criminal division in Washington are collaborating with the U.S. Attorney’s Office in Concord, N.H., on the ongoing probe.
n
The affidavit zeroes in on alleged fraudulent billing of healthcare benefit programs for "medically unnecessary services" purportedly rendered in multiple districts, including Massachusetts and New Hampshire. It asserts that the company submitted claims that deliberately "misrepresented the place of service, rendering provider and medical necessity of the services."
n
More damningly, the affidavit claims the company, through an affiliated billing arm, "additionally billed for services that did not qualify as legitimate medical treatment, such as when a client is napping or watching television." This suggests a fundamental deviation from the therapeutic objectives of Applied Behavior Analysis (ABA) therapy, which is meant to be intensive and highly structured. The core of the accusation is that ABA Centers of America allegedly provided these purported therapy services "based not on medical necessity, but based on an internal rating system which categorized child and teenage patients based on the potential profits that ABACA can earn from that patient’s health insurance."
n
Investigators gleaned much of this information from interviews with multiple former ABA employees and patients. For instance, these conversations revealed a practice of billing services provided in Massachusetts as though they originated in New Hampshire. The motive behind this alleged geographical misrepresentation was clear: insurance plans in New Hampshire offered significantly higher reimbursement rates than those in Massachusetts, allowing the company to inflate its earnings.
n
The affidavit further alleges that the company’s founder, Christopher M. Barnett, leveraged "ill-gotten proceeds from this fraudulent billing to make extravagant purchases to support a lavish lifestyle, such as luxury automobiles." Specific examples cited include the acquisition of a corporate jet and the leasing of a multi-million dollar waterfront home in Fort Lauderdale, painting a stark contrast between the company’s mission to serve vulnerable children and the alleged personal enrichment of its leader.
n
A Chronology of Rapid Growth and Mounting Scrutiny
n
2020: Foundation and Meteoric RisenABA Centers of America was founded in 2020 by Christopher M. Barnett, a self-described serial entrepreneur with a background in real estate and a law degree from Nova Southeastern University. The company, operating under the umbrella of ICBD Holdings, quickly established itself as a "disruptor" in the autism therapy space. Its business model, which it claims addresses long waiting lists for care, fueled an unprecedented growth trajectory. By 2024, it was ranked No. 5 on the Inc. 5000 list of fastest-growing private companies, climbing to No. 25 nationally and No. 15 in the Southeast regional list the following year. The company expanded rapidly, adding locations in Florida under the ABA Centers of Florida banner starting in 2022, with centers in Port St. Lucie, Jensen Beach, Tamarac, Boca Raton, West Palm Beach, and Orlando, among others, and soon boasted over 2,000 employees across more than 10 states.
n
Early 2025: Federal Investigation InitiatesnThe U.S. Department of Health and Human Services in New Hampshire initiated its federal investigation into ABA Centers of America’s billing practices. A federal magistrate granted investigators access to the emails and other electronic communications of founder Christopher M. Barnett and several high-ranking company officials, indicating the seriousness and breadth of the probe from its early stages.
n
October 2025: Temple University Pledge and RenamingnDespite the ongoing federal investigation, its existence remained largely undisclosed to the public. In October 2025, Temple University announced it had accepted a monumental $55 million pledge from Christopher M. Barnett for its College of Public Health. In recognition of this, the largest gift in the university’s history, the institution renamed the college the "Christopher M. Barnett College of Public Health."
n
Late 2025: Civil Litigation IntensifiesnWhile the federal probe continued, ABA Centers of America found itself embroiled in significant civil litigation. Publix Super Markets and its insurance plan, Publix Super Markets, Inc. Group Health Benefits, moved a counterclaim to the federal court in the Middle District of Florida, subsequently transferred to the Southern District of Florida in Fort Lauderdale. The lawsuit alleged a scheme under the Racketeer Influenced and Corrupt Organizations (RICO) Act, seeking approximately $15 million in damages.
n
Around the same time, similar civil litigation unfolded in Massachusetts. Harvard Pilgrim Health Care and Point32Health Services filed an amended counterclaim against ABA Centers and its related entity, Integrative Healthcare Services. They alleged a "far-reaching scheme" to defraud their companies, seeking more than $19 million in damages.
n
August 28, 2026: Key Ruling in Publix CasenU.S. District Judge Raag Singhal issued a pivotal order, allowing the bulk of the Publix case against ABA Centers of America to proceed. He permitted six of the nine counts in the lawsuit to stand, underscoring the potential validity of the allegations. Judge Singhal’s order explicitly noted, "Before the court is a civil case that could also be brought as a criminal action," highlighting the severe nature of the claims. He also articulated the alleged fraud scheme, where ABA Centers submitted inflated bills, knowing that insurers would pay a large percentage while plan members paid a "de minimis amount," thereby deceiving insurers into paying far more than they should have.
n
Early September 2026: Public Disclosure and Temple University’s ReversalnThe existence of the federal investigation was first brought to public light by Samantha Parnham, a certified behavioral health analyst, through her Substack publication, "Reinforcement & Ruin." This online outlet published a six-part series detailing the federal investigation based on court records, as well as the various civil litigations.
n
Following this public disclosure, in early September, Temple University’s President John Fry and Board Chair Mitchell L. Morgan announced a "mutually agreed" termination of Barnett’s $55 million philanthropic commitment. They also confirmed that no money had been paid toward the pledge and that the college would revert to its original name.
n
Supporting Data and Legal Perspectives
n
The core of the federal investigation is built upon the comprehensive 81-page affidavit, which meticulously outlines the alleged fraudulent activities. Beyond the financial misrepresentations, the affidavit highlights how the company’s internal profit-driven metrics allegedly superseded medical necessity in determining patient care. This practice, if proven, represents a profound ethical breach in the provision of critical healthcare services for individuals with autism.
n
Judge Singhal’s detailed description of the alleged billing scheme in the Publix case provides crucial context and supports the federal allegations. He wrote, "Plaintiffs allege that Defendants submitted inflated bills to Plaintiffs and intended Plaintiffs to calculate the amount owed under the insurance plan based off the inflated amounts, even though Defendants never intended to collect significant portions of those totals from the employee Plan Members who received treatment." He illustrated with an example: a $1,000 bill for a 15-minute appointment where the insurer pays 60% ($600) and the plan member 40% ($400). The company, however, would only collect the $600 from the insurer and a "de minimis amount" from the plan member, effectively making the $1,000 billed total false, as they never intended to collect the full amount. This, according to the judge, amounted to fraud, as "Plaintiffs paid almost the entirety of what Defendants collected, when they should have paid far less."
n
The total financial exposure from the civil lawsuits alone is substantial, with Publix seeking approximately $15 million and Point32 subsidiaries seeking over $19 million. These figures underscore the scale of the alleged overbilling and potential damages. The Racketeer Influenced and Corrupt Organizations (RICO) Act counterclaim by Publix is particularly serious, as it alleges a pattern of criminal activity rather than isolated incidents, and carries the potential for treble damages.
n
Industry publications like Behavior Health Business and Acuity Media have also chronicled the emerging legal developments, signaling growing concern within the behavioral health community about the implications of these allegations. Reports of layoffs and facility closures within ABA Centers of America this year further suggest the company may already be feeling the financial and operational strain of these legal challenges.
n
Official Responses and Denials
n
Maria Isina Areco, director of public relations for ABA Centers of America and ICBD Holdings, provided the company’s official stance in an emailed statement to the South Florida Sun Sentinel: "We are aware that the federal government is investigating the company. We are working with federal investigators and will respond at the appropriate time."
The company’s statement also attempted to contextualize the situation by describing its business model as "disruptive to the status quo" and asserting, "We always knew that our business model is disruptive to the status quo and upends current business models for both providers and payors." Crucially, they added, "It is also important to note that this investigation does not appear to be focused on the quality of the care that we provide."
ABA Centers emphasized its mission, stating, "We have always been guided by our mission to deliver life-changing outcomes for people with autism, and their families, and a number of principles that are fundamental to it. First and foremost, we are committed to getting children off waiting lists where they often languish for far too long." They also claimed to prioritize "early treatment" and "individualized care programs where the level (and type) of care is determined by data," and noted increased investment in "staff training on compliance and documentation of our work."
Temple University, in their campus-wide letter announcing the termination of the pledge, stated that Christopher M. Barnett "strenuously" denied any wrongdoing. The university leaders also mentioned that Barnett was dealing with a "life-threatening" medical issue, though they did not elaborate. Neither Temple nor ABA Centers has responded to questions regarding Barnett’s health or his current role within the company.
It is important to note that, despite the comprehensive nature of the affidavit and the severity of the allegations, the federal investigation has not yet resulted in any criminal charges against any business or person. This emphasizes that these are currently allegations, and individuals and entities are presumed innocent until proven guilty in a court of law.
Implications: A Shaking of Foundations
The ongoing federal investigation and multiple civil lawsuits against ABA Centers of America carry profound implications for the company, its founder, the autism therapy industry, and even philanthropic institutions.
For ABA Centers of America: The immediate future of the company is fraught with uncertainty. Legal battles, reputational damage, and potential financial penalties – including massive fines and restitution – could severely impact its operations. Reports of layoffs and facility closures already hint at internal restructuring and challenges. The long-term viability of a company built on a "disruptive" model now under such intense scrutiny remains to be seen. Furthermore, the role and future of founder Christopher M. Barnett, given the allegations of personal enrichment and his reported health issues, are highly uncertain.
For the Autism Therapy Industry: This case could serve as a wake-up call and a catalyst for increased regulatory oversight within the rapidly expanding autism therapy sector. ABA therapy, while widely recognized as an effective intervention, is also expensive and often long-term, making it a target for fraudulent billing practices. This scandal could lead to stricter guidelines for insurance reimbursement, enhanced scrutiny of provider billing, and a renewed focus on ethical practices over profit-driven models. It also risks eroding public trust in ABA providers, potentially making it harder for legitimate, ethical centers to gain authorization and funding for essential services.
For Healthcare Payors: Insurers like Publix and Point32Health Services are increasingly sophisticated in detecting fraud. This case highlights the significant financial losses that can be incurred through alleged fraudulent schemes and reinforces the need for rigorous auditing and verification processes. The success of these civil lawsuits could set precedents for how insurers challenge and recover funds from alleged healthcare fraud.
For Philanthropy and Universities: Temple University’s experience serves as a cautionary tale for institutions accepting large donations, particularly from rapidly growing companies or individuals whose wealth has accumulated quickly. The importance of thorough due diligence on donors and their sources of wealth before accepting pledges and granting naming rights will likely be underscored by this incident.
For Patients and Families: Ultimately, the most significant impact could be on the thousands of children and families who rely on ABA therapy. While ABA Centers asserts that the investigation is not focused on the quality of care, allegations of billing for medically unnecessary services or for non-therapeutic activities could undermine trust and raise concerns about the actual benefit received by patients. The broader consequence could be a more challenging landscape for families seeking timely and effective autism care, as insurers and regulators become more cautious.
As the federal investigation continues and the civil litigations proceed through the courts, the full extent of the alleged misconduct and its repercussions will gradually become clear. The case of ABA Centers of America stands as a potent reminder of the complexities and vulnerabilities within the healthcare system, particularly in high-demand, high-cost specialized fields, and the critical importance of integrity in patient care and financial practices.
